Eurasian Cancer Research Council Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 29-07-2024
- Paid Up Capital ₹ 0.10 M
as on 29-07-2024
- Company Age 7 Year, 5 Months
- Last Filing with ROC 31 Mar 2023
- Revenue 11.23%
(FY 2023)
- Profit -79.29%
(FY 2023)
- Ebitda -79.79%
(FY 2023)
- Net Worth -22.99%
(FY 2023)
- Total Assets 15.09%
(FY 2023)
About Eurasian Cancer Research Council
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Vasave Jayant and Dilip Gavit serve as directors at the Company.
- CIN/LLPIN
U85200MH2017NPL297682
- Company No.
297682
- Company Classification
Private Not For Profit Company
- Incorporation Date
21 Jul 2017
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Chembur, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Eurasian Cancer Research Council?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vasave Jayant  | Director | 21-Jul-2017 | Current |
| Dilip Gavit | Director | 21-Jul-2017 | Current |
Financial Performance of Eurasian Cancer Research Council.
Eurasian Cancer Research Council, for the financial year ended 2023, experienced significant growth in revenue, with a 11.23% increase. The company also saw a substantial fall in profitability, with a 79.29% decrease in profit. The company's net worth observed a substantial decline by a decrease of 22.99%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Eurasian Cancer Research Council?
In 2023, Eurasian Cancer Research Council had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Eurasian Cancer Research Council?
Unlock and access historical data on people associated with Eurasian Cancer Research Council, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Eurasian Cancer Research Council, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Eurasian Cancer Research Council's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
